https://www.selleckchem.com/pr....oducts/Vorinostat-sa
d good response to symptomatic treatments, it is essential to run a fast diagnostic workup. To compare the amplitude changes in motor evoked potentials (MEP) with reversal of residual neuromuscular blockade using sugammadex or placebo in patients with cervical myelopathy. In this prospective randomized double-blind, placebo-controlled crossover trial, 38 patients with cervical myelopathy undergoing posterior cervical decompression and fusion were randomized to either sugammadex (2mg/kg) or placebo. The primary outcome measure wa
Like
Comment
Share
